Astellas Establishes “Regenerative Medicine Unit”; Aims to Establish Basic Technologies within 1 to 2 Years

April 3, 2014
Astellas Pharma established a new “Regenerative Medicine Unit” on April 1 that will specialize in research on regenerative medicine and cell therapy. The unit’s purpose is to continuously and speedily generate drug candidates for competitively superior regenerative medicine and cell...read more